10 Years Report of Combined Simultaneous Transpupillary Thermotherapy and ICG-based Photodynamic Therapy for Choroidal Melanoma
18 Years
95 Years
Both
Choroidal Melanoma
Trial Information
10 Years Report of Combined Simultaneous Transpupillary Thermotherapy and ICG-based Photodynamic Therapy for Choroidal Melanoma
The study was done in a Clinical practice setting. Forty six eyes of 46 patients with small
or medium-sized choroidal melanomas were treated with i-TTT using infrared light delivered
from a diode laser. All patients were evaluated to rule out systemic metastasis and
underwent a complete ophthalmological evaluation including: Slit lamp biomicroscopy, dilated
fundus examination, Fluorescein angiography, Optical coherence tomography and A/B
ultrasonography. Main outcome measures were: Changes in visual acuity, complications
associated with the treatment and local control of the tumor.
Inclusion Criteria:
- Small and medium-sized choroidal melanoma
- Patients older than 18 years old.
- Patients who can read and signed the informed consent.
Exclusion Criteria:
- Patients with ocular inflammation.
- Patients with another active ocular disease.
Type of Study:
Observational
Study Design:
Observational Model: Case-Only, Time Perspective: Retrospective
Principal Investigator
Peter E Liggett, MD
Investigator Role:
Study Director
Investigator Affiliation:
New England Retina Associates
Authority:
United States: Institutional Review Board
Study ID:
NERA-2
NCT ID:
NCT01253759
Start Date:
January 2009
Completion Date:
March 2009
Related Keywords:
- Choroidal Melanoma
- Transpupillary thermotherapy
- Choroidal melanoma
- ICG-Photodynamic therapy
- Melanoma
Name | Location |
|---|---|
| New England Retina Associates | Hamden, Connecticut 06518 |
